Shawn Czado Email

VP, Market Access . MILLENDO THERAPEUTICS

Ann Arbor, MI

Location

c****@millendo.com

Primary Email

Current Roles

Employees:
6
Revenue:
$465k
About
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing's Syndrome (CS).
MILLENDO THERAPEUTICS Address
110 Miller Avenue
Ann Arbor, MI
United States
MILLENDO THERAPEUTICS Email

Past Companies

Independent Consultant and Sub-Contractor (Ogilvy Health)Market Access Consultant
KalVista Pharmaceuticals, Inc.Head, Global Market Access and Value Demonstration (promoted to Executive Director in 2022)
Independent Consultant and Sub-Contractor (Ogilvy Health & Wunderman Thompson Health)Market Access Consulting

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.